I also have signed to show support. To me the key point, as always, is that CBT/GET trials for ME/CFS, by design, very likely misconstrue harms from treatment as lack of perseverance by the patient; inevitable if you presume a physical illness to be a mental one. These trials are explicitly designed to not recognise harms for what they are, deteriorations in symptoms due to treatment. Only the most severe and immediate harms are going to get reported, and the majority of GET-related harms don't meet these trials' criteria for counting as harms. Maybe these treatments do help a minority of people with an ME/CFS diagnosis, but if nobody is recognising, acknowledging, or giving a damn about genuine harms from these treatments, then that really p*sses me off.I haven' t read all of the ME Action response yet, but the above gives an idea of its content. I've signed to support the response (which people should be aware is still evolving as they get feedback). I think it's important that the CDC gets a clear message. Given the previous gains in the US, that this CDC review could get it so wrong is, well, remarkable.
The situation has gone backwards before there.
I do understand that there is no unified consistent response, but still. Just comes across as either rank incompetence, meaningless bureaucracy with potentially unintended consequences, or someone involved trying to muddy the waters - or a combination of all three.
Maybe it's just a routine thing with the CDC that every x years each evidence review is updated, and if there's a change in evidence then the guidelines are updated too.
That's a wild guess.
Ariel said: ↑
The situation has gone backwards before there.
This has been a big concern of mine that this will happen.
I remember, I think it was about 15 years ago when pages of the then called CFS CDC guidlines became good (with I think one exception in what was said). It was very exciting to me to read it. It described what it was for me clearly and I could share it with doctors and people and then within a very short period of time it went backwards again.
Much to my horror. Certain people I recommended it to saw the new version and not the previous one.
We did it! #MEAction has officially submitted our public comment on the CDC’s flawed review of ME/CFS treatments.
We received 7,209 co-signs from across the ME community supporting our call for the CDC to stop this flawed evidence review from being published. By working together, you helped us send a strong message that GET & CBT are not safe or effective treatments for people with ME.
https://www.meaction.net/2021/08/16/over-7k-sign-meactions-response-to-flawed-cdc-reviewNow it is the CDC’s move. Will they listen to the ME community when we say we deserve better than a flawed, poorly scoped, and executed research review that continues to repeat the mistakes of the past and puts people with ME at risk of harm? The federal public comment process means that the agency is required to provide a response to our public comment and can’t simply ignore our criticism.
What action will the CDC take in the face of such criticism and opposition from the ME community? Can the CDC acknowledge and learn from their mistakes, turning a new page to begin a real partnership with our community? Or will they dig in their heels, ignore the harm of their actions, and destroy our ability to trust the CDC to do the research and education we so desperately need?
Well, CDC that is entirely up to you. Rest assured, we will hold you accountable.
Thank you to everyone who contributed to a truly massive effort over the past several months.
CDC decides not to publish flawed ME/CFS treatments review!
As we enter the holidays we have a positive development to report coming out of yesterday’s ME/CFS stakeholder call with the U.S. Centers for Disease Control and Prevention (CDC). CDC has announced that it will not publish a systematic evidence review of ME/CFS treatments by the Oregon Health Science University Evidence-based Practice Center (EPC) in an academic journal. #MEAction supports this appropriate decision by CDC.
#MEAction had raised multiple concerns with the draft EPC review, and over seven thousand people across the ME community co-signed our public comment, which stated that the EPC review was fundamentally flawed and strongly recommended that it not be published.
CDC Chronic Viral Diseases Branch Chief Dr. Elizabeth Unger also stated in her program updates that “In the interest of transparency, we will be posting the final report, comments and responses on our ME/CFS website.”
During the call, #MEAction advocates asked Dr. Unger for CDC to hold a community meeting to dialogue about how the EPC review information could be shared on the website in an appropriate context to ensure there is no confusion for healthcare providers or harm to patients. Dr. Unger replied that CDC would consider that request.
#MEAction has written a follow-up letter to Dr. Unger underscoring the importance of holding a public community meeting. If the CDC ME/CFS program is unable to organize a meeting themselves, #MEAction will organize a community meeting and invite CDC representatives to participate as panelists.
Read Letter
We will update the community on this important issue and communicate news as it becomes available. Thank you for your continued support of #MEAction’s federal agency advocacy efforts. Progress would not happen without you.
The post CDC decides not to publish flawed ME/CFS treatments review! appeared first on #MEAction Network.